$PALI
PALISADE BIO, INC. Stock $pali

$pali Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000114420414065859 Filed on November 07, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q4
Revenue	$4.666K	$5.000K	$2.500K
YoY Change	86.64%	100.0%	0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.000M	$1.970M	$1.070M
YoY Change	86.92%	15.2%	9.18%
% of Gross Profit
Research & Development	$2.560M	$2.110M	$1.630M
YoY Change	57.06%	14.21%	-4.12%
% of Gross Profit
Depreciation & Amortization	$90.00K	$80.00K	$60.00K
YoY Change	50.0%	0.0%	20.0%
% of Gross Profit
Operating Expenses	$4.640M	$4.112M	$2.770M
YoY Change	67.51%	13.07%	1.47%
Operating Profit	-$4.641M	-$4.107M	-$2.763M
YoY Change	67.99%	13.01%	1.31%
Interest Expense	-$420.0K	$361.6K	-$540.0K
YoY Change	-22.22%	-19.45%	-5500.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$348.5K	$0.00
YoY Change		-88.59%
Pretax Income	-$5.500M	-$4.460M	-$3.300M
YoY Change	66.67%	-33.33%	21.77%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.503M	-$4.455M	-$3.303M
YoY Change	66.6%	-33.37%	21.67%
Net Earnings / Revenue	-117941.88%	-89104.74%	-132127.52%
Basic Earnings Per Share
Diluted Earnings Per Share	-$91.67M	-$74.33M	-$66.00M
COMMON SHARES
Basic Shares Outstanding	87.36M shares	86.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.53M	$26.95M	$16.85M
YoY Change	63.38%	64.33%	126.48%
Cash & Equivalents	$12.52M	$11.95M	$16.85M
Short-Term Investments	$15.01M	$15.01M
Other Short-Term Assets	$410.0K	$750.0K	$770.0K
YoY Change	-46.75%	-18.48%	266.67%
Inventory
Prepaid Expenses	$274.1K	$409.1K	$255.7K
Receivables	$225.5K	$32.76K	$10.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$28.16M	$27.73M	$17.62M
YoY Change	59.84%	60.05%	130.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$301.3K	$301.3K	$231.0K
YoY Change	30.43%	18.82%	0.25%
Goodwill
YoY Change
Intangibles	$1.233M	$1.246M	$1.138M
YoY Change	8.39%	18.85%	40.92%
Long-Term Investments
YoY Change
Other Assets	$58.71K	$57.72K	$64.90K
YoY Change	-9.53%	-11.01%	8.95%
Total Long-Term Assets	$1.682M	$1.709M	$1.794M
YoY Change	-6.25%	-6.98%	63.53%
TOTAL ASSETS
Total Short-Term Assets	$28.16M	$27.73M	$17.62M
Total Long-Term Assets	$1.682M	$1.709M	$1.794M
Total Assets	$29.84M	$29.44M	$19.41M
YoY Change	53.73%	53.62%	121.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.500M	$2.440M	$1.200M
YoY Change	108.33%	101.65%	0.0%
Accrued Expenses	$650.0K		$470.0K
YoY Change	38.3%		0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$730.0K	$3.058M	$2.763M
YoY Change	-73.58%	53.99%
Total Short-Term Liabilities	$4.009M	$5.705M	$5.936M
YoY Change	-32.47%	10.82%	237.99%
LONG-TERM LIABILITIES
Long-Term Debt	$8.056M	$2.611M	$4.934M
YoY Change	63.28%	-53.87%
Other Long-Term Liabilities	$60.00K	$220.0K	$130.0K
YoY Change	-53.85%	144.44%	550.0%
Total Long-Term Liabilities	$8.056M	$2.611M	$4.934M
YoY Change	63.28%	-53.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.009M	$5.705M	$5.936M
Total Long-Term Liabilities	$8.056M	$2.611M	$4.934M
Total Liabilities	$12.12M	$8.539M	$11.00M
YoY Change	10.27%	-21.65%	518.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$151.1M	-$145.6M	-$128.4M
YoY Change	17.62%	16.33%	18.26%
Common Stock	$877.9K	$871.6K	$778.9K
YoY Change	12.72%	13.69%	14.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.72M	$20.90M	$8.418M
YoY Change
Total Liabilities & Shareholders Equity	$29.84M	$29.44M	$19.41M
YoY Change	53.73%	53.62%	121.87%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q4
OPERATING ACTIVITIES
Net Income	-$5.503M	-$4.455M	-$3.303M
YoY Change	66.6%	-33.37%	21.67%
Depreciation, Depletion And Amortization	$90.00K	$80.00K	$60.00K
YoY Change	50.0%	0.0%	20.0%
Cash From Operating Activities	-$3.480M	-$3.110M	-$2.470M
YoY Change	40.89%	38.22%	-1.98%
INVESTING ACTIVITIES
Capital Expenditures	-$80.00K	-$90.00K	-$100.0K
YoY Change	-20.0%	-55.0%	66.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$10.00K
YoY Change
Cash From Investing Activities	-$70.00K	-$100.0K	-$100.0K
YoY Change	-30.0%	-50.0%	66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.130M	-90.00K	3.010M
YoY Change	37.21%	-101.17%	1906.67%
NET CHANGE
Cash From Operating Activities	-3.480M	-3.110M	-2.470M
Cash From Investing Activities	-70.00K	-100.0K	-100.0K
Cash From Financing Activities	4.130M	-90.00K	3.010M
Net Change In Cash	580.0K	-3.300M	440.0K
YoY Change	31.82%	-163.1%	-118.11%
FREE CASH FLOW
Cash From Operating Activities	-$3.480M	-$3.110M	-$2.470M
Capital Expenditures	-$80.00K	-$90.00K	-$100.0K
Free Cash Flow	-$3.400M	-$3.020M	-$2.370M
YoY Change	43.46%	47.32%	-3.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1417527	USD
CY2013Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	8000000	USD
CY2013Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	2000000	USD
CY2013Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.11	pure
CY2014Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.11	pure
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2016-06-30
	cur	Debt Instrument Weighted Average Interest Rate DebtInstrumentWeightedAverageInterestRate	0.11	pure
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	7551000	USD
CY2013Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	300000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11945253	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16846052	USD
CY2014Q3	us-gaap	Short Term Investments ShortTermInvestments	15007478	USD
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32761	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10000	USD
CY2014Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	339752	USD
CY2013Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	507334	USD
CY2014Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	409140	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	255733	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	27734384	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	17619119	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	301282	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	230971	USD
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1245502	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1137701	USD
CY2014Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	104407	USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	360848	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	57720	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	64897	USD
CY2014Q3	us-gaap	Assets Assets	29443295	USD
CY2013Q4	us-gaap	Assets Assets	19413536	USD
CY2014Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2444039	USD
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1662058	USD
CY2014Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	3058495	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	27950386	USD
CY2014Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	18835580	shares
	cur	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	18776	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	13127	USD
	us-gaap	Interest Expense InterestExpense	936471	USD
	us-gaap	Interest Expense InterestExpense	1191976	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	448943	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2763121	USD
CY2014Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2014Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	202383	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	93426	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5704917	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5936132	USD
CY2014Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2611421	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4934210	USD
CY2014Q3	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	222970	USD
CY2013Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	124995	USD
CY2014Q3	us-gaap	Liabilities Liabilities	8539308	USD
CY2013Q4	us-gaap	Liabilities Liabilities	10995337	USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	871557	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	778860	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	165577933	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	136058135	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6110	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7241	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-145551613	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128426037	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	20903987	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	8418199	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29443295	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19413536	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2080740	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3638972	USD
CY2013Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1007453	USD
CY2014Q3	us-gaap	Share Based Compensation ShareBasedCompensation	656947	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18577207	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	863393	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	322231	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	282789	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18835580	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14014963	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	18835580	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.79
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.26
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.89
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.20
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.89
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.07
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.89
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y3M18D
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	24000710	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1310344	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	27950386	USD
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	18523332	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.69
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.93
CY2013Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	350650	shares
CY2013Q1	cur	Warrants Issued During Period WarrantsIssuedDuringPeriod	258000	shares
CY2013Q1	cur	Class Of Warrant Or Right Exercise Price Of Warrants Issued ClassOfWarrantOrRightExercisePriceOfWarrantsIssued	1.25
CY2013Q1	us-gaap	Share Price SharePrice	1.25
CY2013Q1	cur	Stock Issued During Period Share From Warrants In Conjunction With Debt Transaction StockIssuedDuringPeriodShareFromWarrantsInConjunctionWithDebtTransaction	1297607	shares
CY2013Q1	cur	Warrants And Shares Issued Value Net WarrantsAndSharesIssuedValueNet	323000	USD
CY2013Q1	cur	Stock Issued During Period Share From Warrants Exercised StockIssuedDuringPeriodShareFromWarrantsExercised	258000	shares
CY2013Q1	cur	Warrants Expiration Date WarrantsExpirationDate	2020-03-31
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	4708000	USD
	cur	Compensation Expenses Unvested Stock Option Term Period CompensationExpensesUnvestedStockOptionTermPeriod	P2Y2M12D
	cur	Compensation Expenses Unvested Restricted Stock Term Period CompensationExpensesUnvestedRestrictedStockTermPeriod	P6M
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2000000	USD
CY2014Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	44400000	shares
	cur	Compensation Expenses Unvested Restricted Stockoutstanding Value CompensationExpensesUnvestedRestrictedStockoutstandingValue	45000	USD
CY2013Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.25
	cur	Class Of Warrant Or Right Expense Recognized ClassOfWarrantOrRightExpenseRecognized	3100000	USD
CY2014Q2	cur	Increase Decrease In Common Stock Shares Authorized IncreaseDecreaseInCommonStockSharesAuthorized	150000000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87155672	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77886031	shares
	us-gaap	Revenues Revenues	107500	USD
	us-gaap	Revenues Revenues	14167	USD
CY2013Q3	us-gaap	Revenues Revenues	2500	USD
CY2014Q3	us-gaap	Revenues Revenues	5000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5502137	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5577644	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1847403	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2058865	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4184740	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6971186	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1707690	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1969879	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	181991	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	260221	USD
CY2013Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	81393	USD
CY2014Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	83001	USD
	us-gaap	Operating Expenses OperatingExpenses	9868868	USD
	us-gaap	Operating Expenses OperatingExpenses	12809051	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	3636486	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	4111745	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9761368	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12794884	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3633986	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4106745	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	45336	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	55267	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	361619	USD
	cur	Warrant Modification Expense WarrantModificationExpense	5017156	USD
	cur	Warrant Modification Expense WarrantModificationExpense	3109850	USD
CY2013Q3	cur	Warrant Modification Expense WarrantModificationExpense	1945214	USD
CY2014Q3	cur	Warrant Modification Expense WarrantModificationExpense	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	859682	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	334133	USD
CY2013Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	677883	USD
CY2014Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Other Income OtherIncome	667	USD
	us-gaap	Other Income OtherIncome	250000	USD
CY2013Q3	us-gaap	Other Income OtherIncome	293	USD
CY2014Q3	us-gaap	Other Income OtherIncome	0	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6767306	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4330692	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3052971	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-348492	USD
	us-gaap	Net Income Loss NetIncomeLoss	-16528674	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17125576	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-6686957	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-4455237	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70533035	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	86777197	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	72986698	shares
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	87366234	shares
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	6101	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-1131	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	6101	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	3	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-16522573	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-17126707	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-6680856	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-4455234	USD
	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	462794	USD
	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	622244	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4167	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22761	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-38849	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-56221	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5172	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-7131	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-191686	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	899299	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-18541	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3191	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-8651	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-9261	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8115679	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8226336	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	25007478	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	325783	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	308136	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	118938	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	172171	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-444721	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-15487785	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5836346	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1661865	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	133000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4241640	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	19467859	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7551329	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	cur	Payment Of Employee Taxes On Stock Option Exercise PaymentOfEmployeeTaxesOnStockOptionExercise	0	USD
	cur	Payment Of Employee Taxes On Stock Option Exercise PaymentOfEmployeeTaxesOnStockOptionExercise	426212	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1917353	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	81362	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	104957	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	35000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	17512953	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	18814202	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	5402	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-880	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8957955	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4900799	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7443773	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16401728	USD
	us-gaap	Interest Paid InterestPaid	399960	USD
	us-gaap	Interest Paid InterestPaid	573869	USD
	cur	Issuance Of Warrants For Vendor Services IssuanceOfWarrantsForVendorServices	658326	USD
	cur	Issuance Of Warrants For Vendor Services IssuanceOfWarrantsForVendorServices	0	USD
	cur	Issuance Of Common Stock For Cashless Excercise Of Warrants IssuanceOfCommonStockForCashlessExcerciseOfWarrants	587500	USD
	cur	Issuance Of Common Stock For Cashless Excercise Of Warrants IssuanceOfCommonStockForCashlessExcerciseOfWarrants	838213	USD
	cur	Issuance Of Common Stock For Cash Less Excercise Of Option IssuanceOfCommonStockForCashLessExcerciseOfOption	0	USD
	cur	Issuance Of Common Stock For Cash Less Excercise Of Option IssuanceOfCommonStockForCashLessExcerciseOfOption	369867	USD
	cur	Issuance Of Common Stock Related To Debt Issuance Fees IssuanceOfCommonStockRelatedToDebtIssuanceFees	396234	USD
	cur	Issuance Of Common Stock Related To Debt Issuance Fees IssuanceOfCommonStockRelatedToDebtIssuanceFees	0	USD
	cur	Issuance Of Warrants For Fees Related To Debt Issuance IssuanceOfWarrantsForFeesRelatedToDebtIssuance	452187	USD
	cur	Issuance Of Warrants For Fees Related To Debt Issuance IssuanceOfWarrantsForFeesRelatedToDebtIssuance	0	USD
	dei	Entity Registrant Name EntityRegistrantName	Neuralstem, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001357459
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Trading Symbol TradingSymbol	CUR
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	87359665	shares
	cur	Financing Of Insurance Premiums Through Note Payable FinancingOfInsurancePremiumsThroughNotePayable	183472	USD
	cur	Financing Of Insurance Premiums Through Note Payable FinancingOfInsurancePremiumsThroughNotePayable	210722	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	10000000	USD
CY2014Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	249000	USD
CY2014Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	200371	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3

Files In Submission

Name	View Source	Status
0001144204-14-065859-index-headers.html	Edgar Link	pending
0001144204-14-065859-index.html	Edgar Link	pending
0001144204-14-065859.txt	Edgar Link	pending
0001144204-14-065859-xbrl.zip	Edgar Link	pending
cur-20140930.xml	Edgar Link	completed
cur-20140930.xsd	Edgar Link	pending
cur-20140930_cal.xml	Edgar Link	unprocessable
cur-20140930_def.xml	Edgar Link	unprocessable
cur-20140930_lab.xml	Edgar Link	unprocessable
cur-20140930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v391812_10q.htm	Edgar Link	pending
v391812_ex31-1.htm	Edgar Link	pending
v391812_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PALI
PALISADE BIO, INC. Stock $pali

2014 Q4 Form 10-Q Financial Statement

#000114420414065859 Filed on November 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PALI PALISADE BIO, INC. Stock $pali

2014 Q4 Form 10-Q Financial Statement

#000114420414065859 Filed on November 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PALI
PALISADE BIO, INC. Stock $pali